- Home
- EXLS vs ELAN Comparison
EXLS vs ELAN Comparison
Compare EXLS & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXLS
- ELAN
- Stock Information
- Founded
- EXLS 1999
- ELAN 1954
- Country
- EXLS United States
- ELAN United States
- Employees
- EXLS N/A
- ELAN N/A
- Industry
- EXLS Business Services
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- EXLS Consumer Discretionary
- ELAN Health Care
- Exchange
- EXLS Nasdaq
- ELAN Nasdaq
- Market Cap
- EXLS 7.0B
- ELAN 6.6B
- IPO Year
- EXLS 2006
- ELAN 2018
- Fundamental
- Price
- EXLS $44.65
- ELAN $14.73
- Analyst Decision
- EXLS Strong Buy
- ELAN Buy
- Analyst Count
- EXLS 7
- ELAN 7
- Target Price
- EXLS $49.57
- ELAN $15.33
- AVG Volume (30 Days)
- EXLS 3.1M
- ELAN 5.3M
- Earning Date
- EXLS 07-31-2025
- ELAN 08-07-2025
- Dividend Yield
- EXLS N/A
- ELAN N/A
- EPS Growth
- EXLS 21.21
- ELAN N/A
- EPS
- EXLS 1.32
- ELAN 0.75
- Revenue
- EXLS $1,902,884,000.00
- ELAN $4,427,000,000.00
- Revenue This Year
- EXLS $14.18
- ELAN $4.28
- Revenue Next Year
- EXLS $11.53
- ELAN $4.67
- P/E Ratio
- EXLS $33.77
- ELAN $19.61
- Revenue Growth
- EXLS 14.18
- ELAN 1.42
- 52 Week Low
- EXLS $31.02
- ELAN $8.02
- 52 Week High
- EXLS $52.43
- ELAN $15.78
- Technical
- Relative Strength Index (RSI)
- EXLS 44.50
- ELAN 71.17
- Support Level
- EXLS $43.58
- ELAN $14.01
- Resistance Level
- EXLS $45.55
- ELAN $14.15
- Average True Range (ATR)
- EXLS 1.28
- ELAN 0.39
- MACD
- EXLS -0.20
- ELAN 0.00
- Stochastic Oscillator
- EXLS 28.88
- ELAN 96.01
About EXLS ExlService Holdings Inc.
ExlService Holdings Inc. is a business process management company that provides digital operations and analytical services to clients driving enterprise-scale business transformation initiatives that leverage the company's deep expertise in analytics, AI, ML, and cloud. The company offers business process outsourcing and automation services, and data-driven insights to customers across multiple industries. The company operates through four segments based on the products and services offered and markets served: Insurance, Healthcare, Emerging Business, and Analytics . The vast majority of the company's revenue is earned in the United States, and more than half of its revenue comes from Analytics segment.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.